Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12913-017-2648-7
Published Online: 2017-11-25
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Matza, Louis S.
Boye, Kristina S.
Stewart, Katie D.
Davies, Evan W.
Paczkowski, Rosirene
Funding for this research was provided by:
Eli Lilly and Company (NA)